For decades, dementia, especially Alzheimer’s disease, was treated as untouchable. Families watched loved ones fade, doctors could offer only reassurance and coping strategies, and research seemed to ...

Memantine, a drug approved for Alzheimer’s disease, was associated with significant improvement in social functioning in some children and adolescents with autism spectrum disorder (ASD) without ...

The dementia drug memantine showed promise for improving social functioning in a small trial of youth with autism. Nine of 16 children and adolescents treated with memantine met the response criteria ...

Alzheimer’s disease is a progressive disease that triggers brain cell deterioration. Over time, this makes things like remembering, learning, controlling emotions, and even basic tasks difficult or ...

Please provide your email address to receive an email when new articles are posted on . Response rates on the SRS-2 and CGI-S were significantly higher in those given memantine. Memantine was also ...

Lewy body disease is a stealthy and relentless brain disorder that affects memory, movement, and core body functions. It includes dementia with Lewy bodies and Parkinson’s disease, with or without ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...

WASHINGTON -- Americans with advanced Alzheimer's disease soon can try the first treatment proved effective for late stages of the mind-robbing illness. Memantine should be on pharmacy shelves by ...

That began to shift in the 1990s, when scientists identified the chemical imbalances in Alzheimer’s brains: lower levels of acetylcholine, a neurotransmitter tied to memory, and glutamate ...